Prognostic and Predictive Effects of Immunohistochemical Factors in High-Risk Primary Breast Cancer Patients

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene1996 · 429 citations
2. 2High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial2004 · 81 citations
3. 3erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer1998 · 618 citations
4. 4Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer2003 · 195 citations
5. 5Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation2000 · 62 citations